Trailblazers in Disruptive Innovation Honored at the 22nd Annual Medical Technologies: A Frost & Sullivan Executive MIndXchange

Tuesday, April 25, 2017 General News
Email Print This Page Comment
Font : A-A+

Companies offering breakthrough products and services unveiled at signature medical device event

SANTA CLARA, Calif., April 25, 2017 /PRNewswire/ -- Key disruptive innovators were recently honored at a special Spotlight on Companies to Action

session at the 22nd Annual Medical Technologies: A Frost & Sullivan Executive MIndXchange. This elite group of trailblazing organizations received an exclusive invitation to the event where they were recognized for their transformational products and services. All were lauded for serving as catalysts for growth on the medical business landscape.

For further information or to register for the 23rd Annual Medical Technologies: A Frost & Sullivan Executive MIndXchange please click here.

Disruptive Innovator Award recipients:

Patrice Allibert, President & Chief Executive Officer, GenePOCProviding in less than one hour the right diagnostic results through smart microfluidic solutions, sustainable and cost contained when and where patients benefit from.

Jeffrey Brewer, President & Chief Executive Officer, Bigfoot BiomedicalUsing secure connected devices and machine learning technology to provide people with insulin-dependent diabetes a comprehensive automated insulin delivery solution delivered as a monthly service.

Colleen Gray, President and Chief Executive Officer, Consensus OrthopedicsCreating transformative wearable technology designed to empower at-home patient rehab and remote monitoring for total joint rehabilitation.

Joni Kettunen, Co-Founder & Chief Executive Officer, FirstbeatTransforming heartbeat data into personalized insights on stress, exercise and sleep.

Sonya Kim, Founder & Chief Executive Officer, One Caring TeamHelping older adults reconnect to life with a relaxation program  with Aloha VR, the new future of brain health.

Naser Partovi, Founder & Chief Executive Officer, Sanitas Inc.Scaling connected care to enable clinical collaboration and engagement that activates patients to improve outcomes.

Rick Randall, Chief Executive Officer, OMNI Life SciencesLeading the clinical transformation to Robotic Assisted Total Knee Replacement Surgery.

Before receiving their awards and recognition, the attendees participated in a one-on-one stage interview with Frost & Sullivan to discuss their unique offerings, as well as the action they are looking to spark with other businesses, ranging from investment, partnering, technology licensing, and other creative services to help ignite innovation.

The 22nd Annual Medical Technologies: A Frost & Sullivan Executive MIndXchange event, themed Innovating for Value in Healthcare, was geared to an executive level audience and included case studies, executive insights, and interactive panels all designed to aid participants in navigating the scope of the technological transformations occurring in healthcare.  Participants benefited from best practice discussions, as well as a highly interactive and collaborative environment.

For additional information, please email: events.us@frost.com  or contact Matthew McSweegan at 516-255-3812.

About Frost & Sullivan   Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.  Contact us: Start the discussion

Contact:

Chiara Carella

Corporate Communications – Global Director

P: +44 (0) 207-343-8314

E: chiara.carella@frost.com 

http://www.frost.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trailblazers-in-disruptive-innovation-honored-at-the-22nd-annual-medical-technologies-a-frost--sullivan-executive-mindxchange-300445178.html

SOURCE Frost & Sullivan



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook